Skip to main content

Advertisement

Table 2 High grade cervical smear cytology report by age and ethnicity among study participants and among women on the National Cervical Screening Programme-Register (NCSP-R) in New Zealand* [15]

From: Type-specific oncogenic human papillomavirus infection in high grade cervical disease in New Zealand

  Study population participants NCSP-R∫
n % N (Jan-Jun 2009) %
Age groups     
20-24 148 24.9 514 22.9
25-29 136 22.9 479 21.4
30-34 92 15.5 348 15.5
35-39 79 13.3 279 12.4
40-44 52 8.8 179 8.0
45-49 34 5.7 165 7.4
50-54 25 4.2 102 4.6
55-59 17 2.9 69 3.1
60-64 7 1.2 73 3.3
65-69 4 0.7 34 1.5
Ethnicity groups     
European/Other 466 78.5 1678 74.9
Maori 98 16.5 367 16.4
Asian 16 2.7 127 5.7
Pacific 14 2.4 70 3.1
Total 594 100 2242 100
  1. * The New Zealand NSCP-R contains cervical cytology results for all women in New Zealand, with the exception of those who choose to opt-off . For the study, and on the NCSP-R, a high grade cytology report includes women with a reported cytology result of either high grade squamous intra-epithelial lesion (HSIL), atypical squamous cells, cannot rule out a high grade lesion (ASC-H), atypical glandular cells(AGC), adenocarcinoma in situ (AIS) or cytology suggestive of invasive cancer (SC, AC1-AC5).
  2. ∫ Screened women with high grade cytology as reported in New Zealand for the period 1st January-30th June 2009[15].